These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2546250)

  • 1. Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha.
    Morrill JC; Jennings GB; Cosgriff TM; Gibbs PH; Peters CJ
    Rev Infect Dis; 1989; 11 Suppl 4():S815-25. PubMed ID: 2546250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey.
    Morrill JC; Czarniecki CW; Peters CJ
    J Interferon Res; 1991 Oct; 11(5):297-304. PubMed ID: 1774469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response.
    Morrill JC; Jennings GB; Johnson AJ; Cosgriff TM; Gibbs PH; Peters CJ
    Arch Virol; 1990; 110(3-4):195-212. PubMed ID: 1690534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Aug; 204(4):617-25. PubMed ID: 21791664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
    Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
    Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
    Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys.
    Cosgriff TM; Morrill JC; Jennings GB; Hodgson LA; Slayter MV; Gibbs PH; Peters CJ
    Rev Infect Dis; 1989; 11 Suppl 4():S807-14. PubMed ID: 2749112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
    Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
    Miller MM; Bennett KE; Drolet BS; Lindsay R; Mecham JO; Reeves WK; Weingartl HM; Wilson WC
    Clin Vaccine Immunol; 2015 Aug; 22(8):930-7. PubMed ID: 26041042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental infection and protection of lambs with a minute plaque variant of Rift Valley fever virus.
    Moussa MI; Abdel-Wahab KS; Wood OL
    Am J Trop Med Hyg; 1986 May; 35(3):660-2. PubMed ID: 3706629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
    Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rift Valley fever infection of rhesus monkeys: implications for rapid diagnosis of human disease.
    Morrill JC; Knauert FK; Ksiazek TG; Meegan JM; Peters CJ
    Res Virol; 1989; 140(2):139-46. PubMed ID: 2756241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of two next-generation Rift Valley fever vaccines.
    Kortekaas J; Oreshkova N; van Keulen L; Kant J; Bosch BJ; Bouloy M; Moulin V; Goovaerts D; Moormann RJ
    Vaccine; 2014 Sep; 32(39):4901-8. PubMed ID: 25050973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
    Faburay B; Wilson WC; Gaudreault NN; Davis AS; Shivanna V; Bawa B; Sunwoo SY; Ma W; Drolet BS; Morozov I; McVey DS; Richt JA
    Sci Rep; 2016 Jun; 6():27719. PubMed ID: 27296136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.